We are live on !
Find out more
TS
Third Security Portfolio holdings
AUM
$241M
Turnover
0%
1-Year Est. Return
45.43%
This Fund
S&P 500
This Quarter Est. Return
-7.78%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$1.59B
AUM Growth
-$383M
(-19%)
Cap. Flow
-$141M
Cap. Flow % of AUM
Cap. Flow %
-8.93%
Top 10 Holdings %
Top 10 Hldgs %
98.92%
Holding
15
New
–
Increased
1
Reduced
3
Closed
–
Avg Time Held
3.3
years
Top 10 Avg Time Held
3
years
Top 20 Avg Time Held
3.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precipio
PRPO
|
+$4.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precigen
PGEN
|
+$122M |
| 2 |
Halozyme
HALO
|
+$23.5M |
| 3 |
AquaBounty Technologies
AQB
|
+$674K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.62% |
| 2 | Energy | 3.69% |
| 3 | Consumer Staples | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Precigen
PGEN
$2.37B
| $1.07B | 67.76% |
56,505,053
-5,930,442
| -9% | -$122M |
2013 Q3
16 quarters
|
|
|
2
Halozyme
HALO
$14B
| $306M | 19.28% |
17,592,771
-1,736,767
| -9% | -$23.5M |
2013 Q2
17 quarters
|
|
3
Alaunos Therapeutics
TCRT
$7.82M
| $59.6M | 3.76% |
64,731
| – | – |
2013 Q2
17 quarters
|
|
|
4
AquaBounty Technologies
AQB
$5.51M
| $42.7M | 2.69% |
299,992
-4,648
| -2% | -$674K |
2017 Q1
2 quarters
|
|
5
Enterprise Products Partners
EPD
$79.4B
| $29.6M | 1.87% |
1,135,734
| – | – |
2013 Q2
17 quarters
|
|
|
FCSC
6
DELISTED
Fibrocell Science Inc.
FCSC
| $17M | 1.07% |
1,108,028
| – | – |
2013 Q2
17 quarters
|
|
7
Energy Transfer Partners
ET
$69.6B
| $14.7M | 0.93% |
847,650
| – | – |
2013 Q2
17 quarters
|
|
8
Theriva Biologics
TOVX
$9.5M
| $12.4M | 0.78% |
1,513
| – | – |
2013 Q2
17 quarters
|
|
9
Oragenics
OGEN
$1.94M
| $6.5M | 0.41% |
860
| – | – |
2013 Q2
17 quarters
|
|
10
DELISTED
NuStar Energy L.P.
NS
| $5.89M | 0.37% |
145,200
| – | – |
2013 Q2
17 quarters
|
|
11
Ocugen
OCGN
$274M
| $5.33M | 0.34% |
44,843
| – | – |
2014 Q4
11 quarters
|
|
|
TCP
12
DELISTED
TC Pipelines LP
TCP
| $5.08M | 0.32% |
97,000
| – | – |
2013 Q2
17 quarters
|
|
|
ETP
13
DELISTED
Energy Transfer Partners, L.P.
ETP
| $3.23M | 0.2% |
176,828
| – | – |
2017 Q2
1 quarter
|
|
|
14
Precipio
PRPO
$39.5M
| $2.94M | 0.19% |
4,530
+2,711
| +149% | +$4.79M |
2017 Q2
1 quarter
|
|
15
Tempest Therapeutics
TPST
$10.4M
| $530K | 0.03% |
128
| – | – |
2013 Q4
15 quarters
|
|
Similar funds
KRC
A
AIA
FG
RFA
UIA
GCM
GMA
Third Security's Q3 2017 Portfolio in Review
As of Q3 2017, Third Security held 15 positions worth $1.59B, down 19% from $1.97B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Third Security withdrew a net $141M in Q3 2017, reducing 3 holdings. Its largest reduction was Precigen, cutting an estimated $122M.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 94% a quarter earlier, followed by Energy and Consumer Staples.
Against the trend, Third Security added an estimated $4.79M to Precipio.
- Third Security added most to Precipio in Q3 2017, an estimated $4.79M increase.
- Third Security's biggest Q3 2017 reduction was Precigen, cutting an estimated $122M.
- Third Security's ten largest holdings make up 99% of its $1.59B portfolio in Q3 2017.
- Third Security opened 0 new positions and closed 0 in Q3 2017.
- Third Security's portfolio value fell 19% quarter-over-quarter to $1.59B.
Based on Third Security's 13F filing for Q3 2017, filed 7 Nov 2017.